The role of the gut microbiota in infectious complications during immunochemotherapy for diffuse large B-cell lymphoma
Our findings suggest that the gut microbiota signatures differ between patients with DLBCL who do and do not develop bacterial infection. The baseline abundance of Enterobacteriaceae is associated with the post-immunochemotherapy bacterial infection, and it has certain predictive value. Detecting the changes of gut microbiota can help predict the risk of bacterial infection after immunochemotherapy.
Authors
- Rongrong Qiu
- Duozhuang Tang (ORCID: https://orcid.org/0000-0002-7725-205X)
- Hua Wang (ORCID: https://orcid.org/0000-0002-0093-9275)
- Chenghui Yu
- Man Sun (ORCID: https://orcid.org/0009-0007-5991-4631)
- Jie Jia (ORCID: https://orcid.org/0000-0003-3238-1947)
- Si Tao (ORCID: https://orcid.org/0000-0001-6956-8516)
- Yuanyuan Wu (ORCID: https://orcid.org/0000-0002-6253-7773)
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s12885-024-13344-w
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Natural Science Foundation of China